S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
66,000% upside on tiny biotech? (Ad)
Stock market today: Asian shares mostly lower after Wall St has its worst week in 6 months
Writers Guild and Hollywood studios reach tentative deal to end strike. No deal yet for actors
66,000% upside on tiny biotech? (Ad)
AI is on the world's mind. Is the UN the place to figure out what to do about it?
Facial recognition technology jailed a man for days. His lawsuit joins others from Black plaintiffs
66,000% upside on tiny biotech? (Ad)
Canadian autoworkers ratify new labor agreement with Ford
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
66,000% upside on tiny biotech? (Ad)
Stock market today: Asian shares mostly lower after Wall St has its worst week in 6 months
Writers Guild and Hollywood studios reach tentative deal to end strike. No deal yet for actors
66,000% upside on tiny biotech? (Ad)
AI is on the world's mind. Is the UN the place to figure out what to do about it?
Facial recognition technology jailed a man for days. His lawsuit joins others from Black plaintiffs
66,000% upside on tiny biotech? (Ad)
Canadian autoworkers ratify new labor agreement with Ford
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
66,000% upside on tiny biotech? (Ad)
Stock market today: Asian shares mostly lower after Wall St has its worst week in 6 months
Writers Guild and Hollywood studios reach tentative deal to end strike. No deal yet for actors
66,000% upside on tiny biotech? (Ad)
AI is on the world's mind. Is the UN the place to figure out what to do about it?
Facial recognition technology jailed a man for days. His lawsuit joins others from Black plaintiffs
66,000% upside on tiny biotech? (Ad)
Canadian autoworkers ratify new labor agreement with Ford
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
66,000% upside on tiny biotech? (Ad)
Stock market today: Asian shares mostly lower after Wall St has its worst week in 6 months
Writers Guild and Hollywood studios reach tentative deal to end strike. No deal yet for actors
66,000% upside on tiny biotech? (Ad)
AI is on the world's mind. Is the UN the place to figure out what to do about it?
Facial recognition technology jailed a man for days. His lawsuit joins others from Black plaintiffs
66,000% upside on tiny biotech? (Ad)
Canadian autoworkers ratify new labor agreement with Ford
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them

ASLAN Pharmaceuticals (ASLN) Stock Forecast, Price & News

$2.01
+0.02 (+1.01%)
(As of 09/22/2023 08:51 PM ET)
Compare
Today's Range
$2.01
$2.06
50-Day Range
$1.96
$2.84
52-Week Range
$1.70
$4.69
Volume
1,400 shs
Average Volume
74,595 shs
Market Capitalization
$32.86 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.67

ASLAN Pharmaceuticals MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
679.4% Upside
$15.67 Price Target
Short Interest
Healthy
1.77% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($3.01) to ($3.63) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.16 out of 5 stars

Medical Sector

484th out of 962 stocks

Pharmaceutical Preparations Industry

216th out of 448 stocks


ASLN stock logo

About ASLAN Pharmaceuticals (NASDAQ:ASLN) Stock

ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal antibody that targets the IL-13 receptor a1 subunit which is being developed for the treatment of atopic dermatitis and other immunology indications; and ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase for the treatment of autoimmune diseases. It has a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd. to develop immuno-oncology therapeutics for markets targeting the AhR pathway. Its partners include Almirall, Array BioPharma, and CSL Limited. The company was founded in 2010 and is headquartered in Singapore.

ASLN Price History

ASLN Stock News Headlines

His system isolated NVIDIA - Here's His Next Buy.
Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.
H.C. Wainwright Keeps Their Buy Rating on Aslan Pharmaceuticals (ASLN)
His system isolated NVIDIA - Here's His Next Buy.
Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.
Piper Sandler Remains a Buy on Aslan Pharmaceuticals (ASLN)
See More Headlines
Receive ASLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ASLAN Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ASLN Company Calendar

Last Earnings
8/11/2023
Today
9/24/2023
Next Earnings (Estimated)
10/27/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ASLN
Employees
34
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$15.67
High Stock Price Forecast
$17.00
Low Stock Price Forecast
$15.00
Forecasted Upside/Downside
+679.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$-51,380,000.00
Pretax Margin
-385.37%

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.60 per share

Miscellaneous

Free Float
15,583,000
Market Cap
$32.86 million
Optionable
Not Optionable
Beta
1.76
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Dr. Carl Alan Jason Morton Firth EMBA (Age 50)
    Ph.D., Founder, CEO & Exec. Director
  • Mr. Kiran Kumar Asarpota (Age 44)
    COO & Head of Fin.
  • Mr. Ben Goodger (Age 60)
    Gen. Counsel
  • Mr. Stephen Doyle (Age 50)
    Chief Bus. Officer
  • Dr. Alexandre Kaoukhov M.D. (Age 49)
    Chief Medical Officer
  • Charlie Hsu
    Investor Relations Director
  • Chi-Chin Wang
    IR & Corp. Devel. Director













ASLN Stock - Frequently Asked Questions

Should I buy or sell ASLAN Pharmaceuticals stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ASLAN Pharmaceuticals in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ASLN shares.
View ASLN analyst ratings
or view top-rated stocks.

What is ASLAN Pharmaceuticals' stock price forecast for 2023?

3 analysts have issued 1 year target prices for ASLAN Pharmaceuticals' stock. Their ASLN share price forecasts range from $15.00 to $17.00. On average, they predict the company's stock price to reach $15.67 in the next twelve months. This suggests a possible upside of 679.4% from the stock's current price.
View analysts price targets for ASLN
or view top-rated stocks among Wall Street analysts.

How have ASLN shares performed in 2023?

ASLAN Pharmaceuticals' stock was trading at $1.80 at the beginning of 2023. Since then, ASLN stock has increased by 11.7% and is now trading at $2.01.
View the best growth stocks for 2023 here
.

Are investors shorting ASLAN Pharmaceuticals?

ASLAN Pharmaceuticals saw a drop in short interest in August. As of August 31st, there was short interest totaling 244,500 shares, a drop of 20.8% from the August 15th total of 308,900 shares. Based on an average trading volume of 124,400 shares, the days-to-cover ratio is currently 2.0 days. Currently, 1.8% of the shares of the company are sold short.
View ASLAN Pharmaceuticals' Short Interest
.

When is ASLAN Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, October 27th 2023.
View our ASLN earnings forecast
.

How were ASLAN Pharmaceuticals' earnings last quarter?

ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) announced its quarterly earnings results on Friday, August, 11th. The company reported ($0.11) earnings per share for the quarter, beating analysts' consensus estimates of ($0.80) by $0.69. The firm earned $12 million during the quarter.

When did ASLAN Pharmaceuticals' stock split?

Shares of ASLAN Pharmaceuticals reverse split on Monday, March 13th 2023. The 1-5 reverse split was announced on Monday, March 13th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, March 13th 2023. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

What other stocks do shareholders of ASLAN Pharmaceuticals own?
When did ASLAN Pharmaceuticals IPO?

(ASLN) raised $60 million in an initial public offering (IPO) on Friday, May 4th 2018. The company issued 7,500,000 shares at a price of $8.05 per share. Leerink Partners and Piper Jaffray acted as the underwriters for the IPO and BTIG, H.C. Wainwright and CLSA were co-managers.

What is ASLAN Pharmaceuticals' stock symbol?

ASLAN Pharmaceuticals trades on the NASDAQ under the ticker symbol "ASLN."

Who are ASLAN Pharmaceuticals' major shareholders?

ASLAN Pharmaceuticals' stock is owned by many different institutional and retail investors. Top institutional shareholders include BVF Inc. IL (6.42%), Schonfeld Strategic Advisors LLC (0.33%), Renaissance Technologies LLC (0.18%), Citadel Advisors LLC (0.00%) and Simplex Trading LLC (0.00%).

How do I buy shares of ASLAN Pharmaceuticals?

Shares of ASLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ASLAN Pharmaceuticals' stock price today?

One share of ASLN stock can currently be purchased for approximately $2.01.

How much money does ASLAN Pharmaceuticals make?

ASLAN Pharmaceuticals (NASDAQ:ASLN) has a market capitalization of $32.86 million. The company earns $-51,380,000.00 in net income (profit) each year or ($3.24) on an earnings per share basis.

How can I contact ASLAN Pharmaceuticals?

ASLAN Pharmaceuticals' mailing address is 83 CLEMENCEAU AVENUE 12-03 UE SQUARE, SINGAPORE U0, 239920. The official website for the company is www.aslanpharma.com. The company can be reached via phone at 65-6817-9598, via email at investor@aslanpharma.com, or via fax at 65-6225-2419.

This page (NASDAQ:ASLN) was last updated on 9/25/2023 by MarketBeat.com Staff

My Account -